Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Acetylcysteine
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬
2Acetylcysteine Effervescent Tablets
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 85 💬
3ACETYLCYSTEINE SODIUM
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 299 💬
4Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
(D00221)
2件: Acetylcysteine,
Atorvastatin
2件: Acetylcysteine (D00221),
Atorvastatin 💬
1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63 💬
5Fluimucil (acetylcysteine)
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 193 💬
6Glatiramer Acetate, N-Acetylcysteine
(D00221)
3件: Acetate,
Acetylcysteine,
Glatiramer
1件: Acetylcysteine (D00221) 💬--1件: 13 💬
7Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 85 💬
8Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 85 💬
9N-acetylcysteine
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬
10N-acetylcysteine (NAC)
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--2件: 51, 299 💬
11N-acetylcysteine capsule
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 6 💬
12N-acetylcysteine syrup
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 53 💬
13N-Acetylcysteine, (NAC)
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 85 💬
14Prescribe N-acetylcysteine tablets
(D00221)
1件: Acetylcysteine1件: Acetylcysteine (D00221) 💬--1件: 90 💬